New dextromethorphan analogs like dextroproporphan are being explored but lack safety data. Researchers need credible toxicity profiles.
Compile and publish safety studies on novel analogs, including receptor binding and side effects. Offer custom research for pharma companies.
Charge for access to detailed reports. Offer consulting for companies developing new analogs.
Start with a literature review on dextroproporphan. Expand to other analogs as interest grows.
The risk is regulatory crackdowns on analogs. Stay focused on research, not promotion.